Gene Symbol | CHRNA7 |
Entrez ID | 1139 |
Uniprot ID | P36544 |
Description | cholinergic receptor, nicotinic alpha 7 |
Chromosomal Location | chr15: 31,923,438-32,173,018 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000187 |
activation of MAPK activity |
The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
IDA |
BP |
GO:0001666 |
response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
IDA |
BP |
GO:0001988 |
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure |
Any process that activates, maintains or increases the frequency, rate or extent of heart contraction as a result of the baroreceptor response to decreased blood pressure. |
IEA |
BP |
GO:0006811 |
ion transport |
The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
NAS |
BP |
GO:0006816 |
calcium ion transport |
The directed movement of calcium (Ca) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IDA|IMP |
BP |
GO:0006874 |
cellular calcium ion homeostasis |
Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell. |
IMP |
BP |
GO:0006897 |
endocytosis |
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
IDA |
BP |
GO:0007271 |
synaptic transmission, cholinergic |
The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse using the neurotransmitter acetylcholine. |
IBA |
BP |
GO:0007613 |
memory |
The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). |
NAS |
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
IMP |
BP |
GO:0008306 |
associative learning |
Learning by associating a stimulus (the cause) with a particular outcome (the effect). |
IEA |
BP |
GO:0014061 |
regulation of norepinephrine secretion |
Any process that modulates the frequency, rate or extent of the regulated release of norepinephrine. |
IEA |
BP |
GO:0030317 |
flagellated sperm motility |
Any process involved in the controlled movement of a flagellated sperm cell. |
IEA |
BP |
GO:0032094 |
response to food |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat. |
IEA |
BP |
GO:0032225 |
regulation of synaptic transmission, dopaminergic |
Any process that modulates the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine. |
IEA |
BP |
GO:0032691 |
negative regulation of interleukin-1 beta production |
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production. |
IEA |
BP |
GO:0032715 |
negative regulation of interleukin-6 production |
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production. |
IEA |
BP |
GO:0032720 |
negative regulation of tumor necrosis factor production |
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production. |
IDA|IMP |
BP |
GO:0034220 |
ion transmembrane transport |
A process in which an ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. |
IDA|IEA |
BP |
GO:0035094 |
response to nicotine |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus. |
IDA |
BP |
GO:0035095 |
behavioral response to nicotine |
Any process that results in a change in the behavior of an organism as a result of a nicotine stimulus. |
IEA |
BP |
GO:0042110 |
T cell activation |
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
IEA |
BP |
GO:0042113 |
B cell activation |
The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
IEA |
BP |
GO:0042391 |
regulation of membrane potential |
Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. |
IEA |
BP |
GO:0045766 |
positive regulation of angiogenesis |
Any process that activates or increases angiogenesis. |
IMP |
BP |
GO:0048149 |
behavioral response to ethanol |
Any process that results in a change in the behavior of an organism as a result of an ethanol stimulus. |
IEA |
BP |
GO:0050728 |
negative regulation of inflammatory response |
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
IEA |
BP |
GO:0050890 |
cognition |
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory. |
IMP|NAS |
BP |
GO:0060112 |
generation of ovulation cycle rhythm |
The process which controls the timing of the type of sexual cycle seen in female mammals. |
IEA |
BP |
GO:0098655 |
cation transmembrane transport |
A process in which a cation is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IDA|TAS |
CC |
GO:0005892 |
acetylcholine-gated channel complex |
A homo- or hetero-pentameric protein complex that forms a transmembrane channel through which ions may pass in response to acetylcholine binding. |
IDA |
CC |
GO:0009897 |
external side of plasma membrane |
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
IEA |
CC |
GO:0016021 |
integral component of membrane |
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
NAS|IEA |
CC |
GO:0016324 |
apical plasma membrane |
The region of the plasma membrane located at the apical end of the cell. |
IEA |
CC |
GO:0030054 |
cell junction |
A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix. |
IEA |
CC |
GO:0030673 |
axolemma |
The portion of the plasma membrane surrounding an axon; it is a specialized trilaminar random mosaic of protein molecules floating within a fluid matrix of highly mobile phospholipid molecules, 7-8 nm in thickness. |
IEA |
CC |
GO:0045211 |
postsynaptic membrane |
A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. |
IEA |
MF |
GO:0001540 |
beta-amyloid binding |
Interacting selectively and non-covalently with beta-amyloid peptide/protein and/or its precursor. |
IPI |
MF |
GO:0004889 |
acetylcholine-activated cation-selective channel activity |
Enables the transmembrane transfer of a cation by a channel that opens upon binding acetylcholine. |
IDA |
MF |
GO:0005230 |
extracellular ligand-gated ion channel activity |
Enables the transmembrane transfer of an ion by a channel that opens when a specific extracellular ligand has been bound by the channel complex or one of its constituent parts. |
IEA |
MF |
GO:0015276 |
ligand-gated ion channel activity |
Enables the transmembrane transfer of an ion by a channel that opens when a specific ligand has been bound by the channel complex or one of its constituent parts. |
TAS |
MF |
GO:0015464 |
acetylcholine receptor activity |
Combining with acetylcholine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
IDA |
MF |
GO:0015643 |
toxic substance binding |
Interacting selectively and non-covalently with a toxic substance, a poisonous substance that causes damage to biological systems. |
IDA |
MF |
GO:0017081 |
chloride channel regulator activity |
Modulates the activity of a chloride channel. |
IDA |
MF |
GO:0022848 |
acetylcholine-gated cation channel activity |
Enables the transmembrane transfer of a cation by a channel that opens when acetylcholine has been bound by the channel complex or one of its constituent parts. |
IDA |
MF |
GO:0042166 |
acetylcholine binding |
Interacting selectively and non-covalently with acetylcholine, an acetic acid ester of the organic base choline that functions as a neurotransmitter, released at the synapses of parasympathetic nerves and at neuromuscular junctions. |
IDA |
MF |
GO:0042803 |
protein homodimerization activity |
Interacting selectively and non-covalently with an identical protein to form a homodimer. |
IDA |
Domain ID | Description |
---|---|
IPR002394 |
Nicotinic acetylcholine receptor |
IPR006029 |
Neurotransmitter-gated ion-channel transmembrane domain |
IPR006201 |
Neurotransmitter-gated ion-channel |
IPR006202 |
Neurotransmitter-gated ion-channel ligand-binding domain |
IPR018000 |
Neurotransmitter-gated ion-channel, conserved site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04020 |
Calcium signaling pathway |
KEGG |
hsa04080 |
Neuroactive ligand-receptor interaction |
KEGG |
hsa04725 |
Cholinergic synapse |
KEGG |
hsa05033 |
Nicotine addiction |
KEGG |
hsa05204 |
Chemical carcinogenesis |
KEGG |
WP706 |
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0002395 |
Alzheimer'S Disease |
C0004310 |
Auditory Perceptual Disorders |
C0004352 |
Autistic Disorder |
C0014548 |
Epilepsy, Generalized |
C0024121 |
Lung Neoplasms |
C0025261 |
Memory Disorders |
C0027626 |
Neoplasm Invasiveness |
C0027746 |
Nerve Degeneration |
C0036572 |
Seizures |
C0037917 |
Spina Bifida Cystica |
C0038587 |
Substance Withdrawal Syndrome |
C0038644 |
Sudden Infant Death Syndrome |
C0040336 |
Tobacco Use Disorder |
C0525041 |
Neurobehavioral Manifestations |
C1306503 |
Congenital Exomphalos |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
ovary |
follicle cells |
parathyroid gland |
glandular cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
APP |
351 |
P05067 |
0.69 |
FYN |
2534 |
P06241 |
0.72 |
PIK3R1 |
5295 |
P27986 |
0.52 |
ATXN1 |
6310 |
P54253 |
0.63 |
ADCY6 |
112 |
O43306 |
0.83 |